Evidence map›Paper›PMID 34833970›Full record

ArticleMolecules (Basel, Switzerland)2021

Photodynamic Therapy with Zinc Phthalocyanine Inhibits the Stemness and Development of Colorectal Cancer: Time to Overcome the Challenging Barriers?

Mahsa Gholizadeh, Mohammad Amin Doustvandi, Fateme Mohammadnejad, Mahdi Abdoli Shadbad, Habib Tajalli, Oronzo Brunetti, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Redox processes in the treatment of advanced skin cancers.Clinical & experimental metastasis · 2026
    Review
  2. Review
  3. Article
  4. Phototherapy in cancer treatment: strategies and challenges.Signal transduction and targeted therapy · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Mahsa GholizadehImmunology Research Center, Tabriz University of Medical Sciences, Tabriz 51666-14731, Iran.
Mohammad Amin DoustvandiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz 51666-14731, Iran.ORCID 0000-0002-3655-2515
Fateme MohammadnejadImmunology Research Center, Tabriz University of Medical Sciences, Tabriz 51666-14731, Iran.ORCID 0000-0002-4107-9689
Mahdi Abdoli ShadbadImmunology Research Center, Tabriz University of Medical Sciences, Tabriz 51666-14731, Iran.ORCID 0000-0003-4865-8779
Habib TajalliBiophotonic Research Center, Islamic Azad University, Tabriz Branch, Tabriz 51579-44533, Iran.
Oronzo BrunettiIstituto Tumori BariGiovanni Paolo II, Istituto Nazionale dei Tumori (IRCCS), 70124 Bari, Italy.ORCID 0000-0002-7014-6828
Antonella ArgentieroIstituto Tumori BariGiovanni Paolo II, Istituto Nazionale dei Tumori (IRCCS), 70124 Bari, Italy.
Nicola SilvestrisIstituto Tumori BariGiovanni Paolo II, Istituto Nazionale dei Tumori (IRCCS), 70124 Bari, Italy.ORCID 0000-0001-7814-7318
Behzad BaradaranImmunology Research Center, Tabriz University of Medical Sciences, Tabriz 51666-14731, Iran.ORCID 0000-0002-8642-6795
Tabriz University of Medical Sciences · IRIstituto Tumori Bari · ITIslamic Azad University of Tabriz · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic therapy (PDT) is a light-based cancer therapy approach that has shown promising results in treating various malignancies. Growing evidence indicates that cancer stem cells (CSCs) are implicated in tumor recurrence, metastasis, and cancer therapy resistance in colorectal cancer (CRC); thus, targeting these cells can ameliorate the prognosis of affected patients. Based on our bioinformatics results, SOX2 overexpression is significantly associated with inferior disease-specific survival and worsened the progression-free interval of CRC patients. Our results demonstrate that zinc phthalocyanine (ZnPc)-PDT with 12 J/cm

Indexed as

ApoptosisCell Line, TumorCell MovementCell SurvivalColorectal NeoplasmsHumansIsoindolesNeoplastic Stem CellsOrganometallic CompoundsPhotochemotherapyPhotosensitizing AgentsZinc CompoundsIsoindolesOrganometallic CompoundsPhotosensitizing AgentsZinc CompoundsZn(II)-phthalocyaninecancer stem cellcolorectal cancermetastasisphotodynamic therapyprognosisstemnesszinc phthalocyanine

Identifiers

PMID34833970
PMCPMC8621355
OpenAlexW3211764250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.